IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan - PubMed (original) (raw)

IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan

M A Salih et al. Genes Immun. 2007 Jan.

Abstract

Post-kala-azar dermal leishmanaisis (PKDL) in Sudan is associated with elevated interferon-gamma (IFN-gamma). To study interferon-gamma pathways in PKDL, we genotyped 80 trios from the Masalit ethnic group for polymorphisms at -470 ins/delTT, -270T/C, -56T/C and +95T/C in IFNGR1 and at -179G/A and +874T/A in IFNG. No associations occurred at IFNG. Global association with haplotypes comprising all four markers at IFNGR1 (chi(2)(10df)=21.97, P=0.015) was observed, associated with a significant (chi(2)(1df)=4.54, P=0.033) bias in transmission of the haplotype insTT T T T and less (chi(2)(1df)=5.59, P=0.018) than expected transmission of insTT C C C. When compared with data on malaria associations from Gambia, the results suggest a complex pattern of haplotypic variation at the IFNGR1 promoter locus associated with different infectious disease in African populations that reflect the complex roles of IFN-gamma in parasite killing versus inflammation and pathogenesis.

PubMed Disclaimer

Similar articles

• Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients.
  Salih MA, Fakiola M, Abdelraheem MH, Younis BM, Musa AM, ElHassan AM, Blackwell JM, Ibrahim ME, Mohamed HS. Salih MA, et al. BMC Infect Dis. 2014 Dec 3;14:662. doi: 10.1186/s12879-014-0662-5. BMC Infect Dis. 2014. PMID: 25466928 Free PMC article.
• Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese population.
  Farouk S, Salih MA, Musa AM, Blackwell JM, Miller EN, Khalil EA, Elhassan AM, Ibrahim ME, Mohamed HS. Farouk S, et al. Public Health Genomics. 2010;13(6):362-7. doi: 10.1159/000272457. Epub 2009 Dec 29. Public Health Genomics. 2010. PMID: 20051670 Free PMC article.
• Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1.
  Mohamed HS, Ibrahim ME, Miller EN, Peacock CS, Khalil EA, Cordell HJ, Howson JM, El Hassan AM, Bereir RE, Blackwell JM. Mohamed HS, et al. Genes Immun. 2003 Jul;4(5):351-5. doi: 10.1038/sj.gene.6363977. Genes Immun. 2003. PMID: 12847550
• Post-kala-azar dermal leishmaniasis--an overview.
  Ganguly S, Das NK, Barbhuiya JN, Chatterjee M. Ganguly S, et al. Int J Dermatol. 2010 Aug;49(8):921-31. doi: 10.1111/j.1365-4632.2010.04558.x. Int J Dermatol. 2010. PMID: 21128917 Review.
• The immunology of post-kala-azar dermal leishmaniasis (PKDL).
  Zijlstra EE. Zijlstra EE. Parasit Vectors. 2016 Aug 23;9(1):464. doi: 10.1186/s13071-016-1721-0. Parasit Vectors. 2016. PMID: 27553063 Free PMC article. Review.

Cited by

• Arsenic exposure to mouse visceral leishmaniasis model through their drinking water linked to the disease exacerbation via modulation in host protective immunity: a preclinical study.
  Ahmed G, Jamal F, Tiwari RK, Singh V, Rai SN, Chaturvedi SK, Pandey K, Singh SK, Kumar A, Narayan S, Vamanu E. Ahmed G, et al. Sci Rep. 2023 Dec 5;13(1):21461. doi: 10.1038/s41598-023-48642-z. Sci Rep. 2023. PMID: 38052913 Free PMC article.
• Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.
  Kumar A, Singh VK, Tiwari R, Madhukar P, Rajneesh, Kumar S, Gautam V, Engwerda C, Sundar S, Kumar R. Kumar A, et al. Front Immunol. 2023 Aug 11;14:1236952. doi: 10.3389/fimmu.2023.1236952. eCollection 2023. Front Immunol. 2023. PMID: 37638047 Free PMC article. Review.
• Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).
  Volpedo G, Pacheco-Fernandez T, Holcomb EA, Cipriano N, Cox B, Satoskar AR. Volpedo G, et al. Front Cell Infect Microbiol. 2021 Jun 8;11:685296. doi: 10.3389/fcimb.2021.685296. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34169006 Free PMC article. Review.
• Epidemiology of Post-Kala-azar Dermal Leishmaniasis.
  Ghosh P, Roy P, Chaudhuri SJ, Das NK. Ghosh P, et al. Indian J Dermatol. 2021 Jan-Feb;66(1):12-23. doi: 10.4103/ijd.IJD_651_20. Indian J Dermatol. 2021. PMID: 33911289 Free PMC article.
• Post kala-azar dermal leishmaniasis: A threat to elimination program.
  Gedda MR, Singh B, Kumar D, Singh AK, Madhukar P, Upadhyay S, Singh OP, Sundar S. Gedda MR, et al. PLoS Negl Trop Dis. 2020 Jul 2;14(7):e0008221. doi: 10.1371/journal.pntd.0008221. eCollection 2020 Jul. PLoS Negl Trop Dis. 2020. PMID: 32614818 Free PMC article. Review.

References

1. 1. Zijlstra EE, el-Hassan AM. Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg. 2001;95(Suppl 1):S59–76. - PubMed
2. 1. Murray HW, Rubin BY, Rothermel CD. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. J Clin Invest. 1983;72:1506–10. - PMC - PubMed
3. 1. Ismail A, El Hassan AM, Kemp K, et al. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile. J Pathol. 1999;189:615–22. - PubMed
4. 1. Gasim S, Elhassan AM, Kharazmi A, et al. The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC) Clin Exp Immunol. 2000;119:523–9. - PMC - PubMed
5. 1. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-g-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;26:1941–1949. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • Ovid Technologies, Inc.
  • PubMed Central

• Research Materials

  • NCI CPTC Antibody Characterization Program